Shideng Bao

14PUBLICATIONS
79CO-AUTHORS
Molecular targetsChemical engineering not elsewhere classifiedHaematological tumoursMedical infection agents (incl. prions)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 02, 2025
A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasis.

Shawn C Chafe, Kui Zhai, Nikoo Aghaei

|Sep 27, 2023
Author Correction: Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma.

Jing Hao, Xiangzi Han, Haidong Huang

|Apr 20, 2023
Sema3C signaling is an alternative activator of the canonical WNT pathway in glioblastoma.

Jing Hao, Xiangzi Han, Haidong Huang

|Feb 22, 2022
USP33 deubiquitinates and stabilizes HIF-2alpha to promote hypoxia response in glioma stem cells.

Aili Zhang, Zhi Huang, Weiwei Tao

|Feb 05, 2022
Pharmacological inhibition of BACE1 suppresses glioblastoma growth by stimulating macrophage phagocytosis of tumor cells.

Kui Zhai, Zhi Huang, Qian Huang

|Jan 05, 2022
Glioblastoma stem cells reprogram chromatin in vivo to generate selective therapeutic dependencies on DPY30 and phosphodiesterases.

Deobrat Dixit, Briana C Prager, Ryan C Gimple

Pageof 3

Frequent Collaborators

5 joint publications

Jeremy N Rich

4 joint publications

Xiaoguang Fang

4 joint publications

Qiulian Wu

4 joint publications

Jennifer S Yu